A risk score combining quantitative hepatitis B surface antigen and core-related antigen levels to predict off-therapy relapse after cessation of nucleos(t)ide analogues in patients with chronic hepatitis B

被引:0
|
作者
Hsu, Y. -C. [1 ]
Tanaka, Y. [2 ,3 ]
Nguyen, M. [4 ]
Chang, C. -Y. [1 ]
Tai, C. -M. [5 ]
Tseng, C. -H. [5 ]
Chen, C. -C. [6 ]
Wu, M. -S. [6 ]
Lin, J. -T. [1 ]
机构
[1] Fu Jen Catholic Univ, Coll Med, New Taipei, Taiwan
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan
[3] Liver Unit, Nagoya, Aichi, Japan
[4] Stanford Univ, Med Ctr, Dept Med, Palo Alto, CA 94304 USA
[5] E Da Hosp, Dept Med, Kaohsiung, Taiwan
[6] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
关键词
D O I
10.1016/S0168-8278(18)31243-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI-303
引用
收藏
页码:S498 / S498
页数:1
相关论文
共 50 条
  • [21] Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues
    Chen, Chien-Hung
    Chiu, Yi-Chun
    Lu, Sheng-Nan
    Lee, Chuan-Mo
    Wang, Jing-Houng
    Hu, Tsung-Hui
    Hung, Chao-Hung
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (24) : 7686 - 7695
  • [22] Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients
    Teresa Broquetas
    Montserrat Garcia-Retortillo
    Miquel Micó
    Lidia Canillas
    Marc Puigvehí
    Nuria Ca?ete
    Susana Coll
    Ana Viu
    Juan Jose Hernandez
    Xavier Bessa
    José A Carrión
    World Journal of Hepatology, 2020, 12 (11) : 1076 - 1088
  • [23] Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues
    Chien-Hung Chen
    Yi-Chun Chiu
    Sheng-Nan Lu
    Chuan-Mo Lee
    Jing-Houng Wang
    Tsung-Hui Hu
    Chao-Hung Hung
    World Journal of Gastroenterology, 2014, (24) : 7686 - 7695
  • [24] Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients
    Broquetas, Teresa
    Garcia-Retortillo, Montserrat
    Mico, Miquel
    Canillas, Lidia
    Puigvehi, Marc
    Canete, Nuria
    Coll, Susana
    Viu, Ana
    Hernandez, Juan Jose
    Bessa, Xavier
    Carrion, Jose A.
    WORLD JOURNAL OF HEPATOLOGY, 2020, 12 (11) : 1076 - 1088
  • [25] Hepatitis B Core-Related Antigen and Quantitative Surface Antigen Augment Risk Stratification of Patients with Acute Hepatitis B
    Tranah, Thomas
    Foulser, Peter
    Wang, Bo
    Bruce, Matthew
    Gill, Upkar Singh
    Dusheiko, Geoffrey M.
    Carey, Ivana
    Agarwal, Kosh
    HEPATOLOGY, 2018, 68 : 1220A - 1221A
  • [26] End-of-therapy Serum Gradient of Hepatitis B Surface Antigen Predicts Off-therapy Durability after Discontinuation of Nucleos(t)ide Analogues
    Hsu, Yao-Chun
    Wu, Chun-Ying
    Chang, Chi-Yang
    Wu, Ming-Shiang
    Kao, Jia-Horng
    Yang, Tzeng-Huey
    Hung, Hsu-Wei
    Lin, Jaw-Town
    HEPATOLOGY, 2015, 62 : 964A - 965A
  • [28] Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B
    Jeng, Wen-Juei
    Chen, Yi-Cheng
    Chien, Rong-Nan
    Sheen, I-Shyan
    Liaw, Yun-Fan
    HEPATOLOGY, 2018, 68 (02) : 425 - 434
  • [29] Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done
    Hsu, Yao-Chun
    Tseng, Cheng-Hao
    Kao, Jia-Horng
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (05) : 1000 - 1001
  • [30] HBV RNA, Hepatitis B Core-Related Antigen, and Quantitative Hepatitis B Surface Antigen Biomarkers to Predict Outcome of Antiviral Therapy
    Debnath, Prasanta
    Rathi, Pravin
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (12) : 2680 - 2681